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Abstract: There is no consensus on the properties of an ideal dressing for treating wounds. The aim of this study was to investigate
the efficacy of dressings using topically administered bitter melon extract with olive oil, pure olive oil, nitrofurazone, and saline in the
healing of ischemic wounds. A sample group of 48 rats was used in the trial. Their wounds were treated with bitter melon extract, pure
olive oil, nitrofurazone, and saline. Data were collected between October 2014 and April 2015. The highest percentage (94.7%) of wound
healing was observed in the bitter melon extract group and the lowest percentage (86.3%) in the nitrofurazone group. At the end of the
21st day, macroscopic reepithelialization was observed in 9 wounds in the bitter melon extract group (75%), in 6 wounds in the pure
olive oil group (50%), and in only 3 wounds in the nitrofurazone and saline groups (25%). It can be concluded that dressing with a bitter
melon extract is more efficient in the treatment of wounds than using nitrofurazone or saline, and that dressing with olive oil accelerates
wound healing, although not as much as dressing with bitter melon extract.
Key words: Ischemic wound, bitter melon, Momordica, wound dressing

1. Introduction
The treatment of wounds is one of the oldest topics of
discussion and has been studied for many years. New
products related to the care of wounds are constantly being
developed, in parallel to continual advances in medicine.
Although there are many dressing products currently on
the market, their high costs are a heavy economic burden
on both individual patients and nation states. Furthermore,
there is no consensus on the properties an ideal dressing
should have for treating wounds (Dorai, 2012; Maver et al.,
2015; Pereira and Bártolo, 2016).
In developing countries, 80% of people use conventional
medicine to treat their health problems (Dandawate et al.,
2016). As a result of this, many recent studies have focused
on what kinds of effective and safe therapeutic agents can
be obtained from natural sources to treat different diseases
(Palamthodi and Lele, 2014; Agyare et al., 2016; Jarić et al.
2018). Various herbs have been used to treat wounds due
to their availability and the low risk of side effects (Kumar
et al., 2013; Budovsky et al., 2015). Bitter melon extract
is one of the herbs most frequently used in Turkey for its
medicinal properties (Pişkin et al., 2014; Dandawate et al.,
2016).

Bitter melon extract, which is formed by incubating
the herb in olive oil, has been used externally for wound
care and orally for the treatment of stomach complaints
caused by peptic ulcers (Wang et al., 2017). Recent studies
conducted on the pharmacological properties of bitter
melon demonstrated that this plant has antidiabetic,
antilipidemic, antioxidant, antibacterial, antiinflammatory,
antiviral, and anticancer activities (Prashanthi et al., 2012;
Nagarani et al., 2014; Panda et al., 2015; Raina et al.,
2016; Mahmoud et al., 2017; Rashid et al., 2017; Saad et
al., 2017). However, there is as of yet a limited number of
studies investigating its effects on healing wounds.
Bitter melon (Momordica charantia) is a thin,
ascending, ivy-like vine that flowers once a year and is a
member of the family Cucurbitaceae. It is cultivated for
medicinal purpose and includes many biologically active
compounds. Among these, momordicin, momorcharin,
momordin, charantin, polipeptide-p, and cucurbitacin
B are the main substances that it contains. Bitter melon
also contains high amounts of vitamin C. The fruit and
leaves of the plant are rich in minerals and vitamins, and
it is an important source of iron, calcium, magnesium,
phosphorus, and vitamin B. Furthermore, it is known
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to contain β-carotene, potassium, vitamin A, and zinc
(Zhang et al., 2016; Jabeen et al. 2017; Jia et al., 2017).
There are many studies in the literature demonstrating
the conventional use of bitter melon as a preventive
and therapeutic herb for a large range of diseases, and
it contains a number of different biological chemical
compounds (Ahmad et al., 2012; Hamissou et al., 2013;
Talukder et al., 2013; Raina et al., 2016).
The mature fruits of the plant have been used in
wound care. Studies investigating the efficacy of the topical
administration of bitter melon extract have demonstrated
that the plant has a significant and effective role in wound
healing due to its wide-spectrum antibacterial, antioxidant,
antiinflammatory, analgesic, and antiulcer properties, and
because it enhances the activities of transforming growth
factor beta (TGF-β) (Prashanthi et al., 2012; Jung et al.,
2013; Hussan et al., 2014; Alippilakkotte et al., 2017; Singh
et al. 2017).
One of the most commonly known properties of
bitter melon is its capacity for healing wounds. It has
been reported that within the process of wound healing,
the plant accelerates the production of growth factors,
induces the proliferation of fibroblasts, and increases the
oxygenation of the wound, an important factor in healing,
by accelerating capillary circulation; it also accelerates the
process of healing due to the antioxidant and antimicrobial
effects of the phytochemical substances such as flavonoids
and glycosides that it contains, and it positively affects the
rate of wound healing, the ability of the wound to contract,
the time for the wound to close, the epithelization process,
and the tension of the wound (Teoh et al., 2009; Süntar et
al., 2010; Prashanthi et al., 2012; Satar et al., 2013; Supraja

and Usha, 2013; Pişkin et al., 2014; İlhan et al., 2015; Singh
et al., 2017).
The aim of this study was to investigate the wound
healing effects of bitter melon extract, and for this
purpose we compared its effects with those of pure olive
oil, nitrofurazone, and saline in the treatment of ischemic
wounds.
2. Materials and methods
2.1. Sample
This study was performed in the Experimental Laboratory
Animals Application and Research Center, Afyon Kocatepe
University, between 15.10.2014 and 01.04.2015. The
sample of the study comprised 48 male Wistar rats 1.5–2
months old and weighing 200–250 g, selected through a
simple randomized sampling method. The power analysis
was calculated as 0.80 with a 0.50 effect size when 12
animals were studied in each group.
The health of the animals used in the study was
checked by a veterinarian in the Experimental Laboratory
Animals Application and Research Center. Due to the
effect of rats potentially dying before the completion of 21
days of treatment and follow-up, and because the effect of
the reproductive cycle on the healing process could not
be precisely deduced, female rats were excluded from the
study.
2.2. Randomization
The rats were classified into the treatment and control
groups via a simple randomization method using a
random number generator. The treatment groups were
the bitter melon group (Group A), the pure olive oil

RATS
(n:48)

Bitter Melon Group
(n: 12)

Olive Oil
Group
(n: 12)

Nitrofurazone
Group

Saline (control)
Group

(n: 12)

(n: 12)

Figure 1. Flowchart and schematics. The top image is a randomization flowchart. The bottom image is a schematic figure of the wounds
to the rats.
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group (Group B), the nitrofurazone group (Group C),
and the saline (control) group (Group D). A total of 48
rats were randomly assigned to the treatment and control
groups according to the order determined by 12 randomly
obtained number combinations (12, 13, 24, 7, 10, 4, 13,
20, 22, 19, 8, 15) (Figure 1). The rats were kept at a room
temperature of 21 °C with a light/dark cycle of 12 h. Each
rat was kept in single cage, fed ad libitum with pellet feed
and water, and allowed to move freely within the cage.
2.3. Treatment materials
The number of large-scale clinical trials on how to prepare
and use bitter melon is insufficient. However, for traditional
wound healing, information on how to prepare the extract
can be found in studies that examine the effectiveness
of bitter melon extract with olive oil (Satar et al., 2013).
In our study, the bitter melon extract with olive oil was
prepared according to the recommended preparation
method for traditional wound healing as stated in the
literature (Satar et al., 2013). In addition, advice was sought
from the Department of Pharmacognosy in the Faculty of
Pharmacy at Ege University. The extract obtained was kept
in a refrigerator until the moment of use.
To produce the bitter melon extract, the mature fruits
of bitter melons harvested from Bursa in August were cut
open with a knife, the red seeds of the fruits were removed,
and the fruit was then cut into small pieces. The fruit (100
g) was then placed into glass jars containing 500 mL of
pure olive oil. The jars were incubated under sunlight for
1.5 months and then homogenized via a sterile spatula
to form a pulp. Nitrofurazone (0.2%, 56 g) ointment was
obtained from a local pharmacy and used in this study.
Extra virgin olive oil from a local market was used as a
pure olive oil with an acidity degree up to 0.8%.
2.4. Ethical considerations
Forty-eight rats were used in the animal experiments
following the Guidelines for the Care and Use of
Laboratory Animals and as approved by the Animal
Studies Local Ethics Committee of Afyon Kocatepe
University (49533702/97).
2.5. Primary outcomes
The primary outcomes of the study were wound healing
percentages, macroscopic reepithelialization, and
histological examination criteria from day 1 to day 21.
2.6. Data collection
Bitter melon extract was obtained from plants from a
single region. The ischemic wound model was created on
the back of each rat by a veterinarian using a bipedicle flap.
Two full layer wounds of 2 × 2 cm were created within the
ischemic area on the 3rd postoperative day. These wounds
were dressed each day for 21 days for each group of rats.
2.7. Ischemic wound creation
In this study, bipedicle flaps were created on the back of the
rats to induce ischemia. Prior to the surgical procedure,
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ketamine (75–100 mg/kg) and xylazine (1–5 mg/kg)
were administered through the intramuscular route to
anesthetize each rat. The hair in an area of 4 × 10 cm
between the scapulae and the iliac processes was softened
with surgical soap and shaved. The rats under anesthesia
were laid in the ventral recumbent position (backs up,
abdomens down) and stabilized. The area of 4 × 10 cm was
marked with a sterile marker pen. Each mark was checked
with a sterile millimetric ruler.
The surgical area was cleaned with antiseptic solution
and the two parallel edges from the scapulae to the iliac
processes were cut with a lancet and tissue scissors.
Flap subcutaneous tissue was then dissected including
the panniculus carnosus (the subcutaneous structure
providing vascularization). The flap was replaced and
sutured using 3/0 silk with 1-cm intervals.
In order to provide standardization of the wound on
the back of each rat, a model was created on millimetric
acetate paper. The model was drawn on this paper so as
to produce square wounds of 2 × 2 cm at a 1-cm distance
from the flap edges in the horizontal position and at a
2-cm distance in the vertical position, one in the cephalic
and one in the caudal positions. Each acetate paper with
the wound model was sterilized using ethylene oxide. The
rats with bipedicle flaps were left unattended for the first
two postoperative days, and the wounds began to form on
the 3rd day. Prior to the procedure the skin was cleansed
with antiseptic solution. The procedure was performed
under sterile conditions and the sterile wound model was
placed on the bipedicle flap area; the borders of the area
were marked with a sterile marker pen. A total of two fulllayer wound defects of 2 × 2 cm were formed on the back
of each rat with the help of a lancet and tissue scissors.
The wounds were 1 cm distant from each other in the
horizontal position and 2 cm apart in the vertical position.
2.8. Wound treatment protocol
The wounds of the rats were treated with bitter melon
extract with olive oil, pure olive oil, nitrofurazone, or
saline for 21 days. The wound areas were cleansed with
sterile saline prior to being dressed. Due to the different
forms and densities of the substances used in the study
and control groups, in order to standardize the dressing
methods the lowest amount that would fill the wound
area was used and this amount was applied with the
help of a sterile spatula to form a thin film layer. One of
3 g of bitter melon extract, 1 mL of pure olive oil with a
maximum acidity of 0.8%, or 1 g of nitrofurazone pomade
was administered onto the wounds of the rats according
to the groups they were assigned to. Sterile saline was
administered only to the rats in the control group. The
wounds were closed with a sterile sponge and the adhesive
bandage was stabilized with the dressing. The wounds of
each rat were dressed once a day in all the groups.
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2.9. Wound healing rates
The unhealed wound area and the percentage of total
wound healing were recorded on each day of measurement
and used for statistical analysis. On the 7th, 14th, and 21st
days the wounds were drawn on millimetric acetate papers.
These were then scanned and transferred to electronic
form. The wound area was calculated using Auto CAD
R14 (Autodesk Inc., San Rafael, CA, USA) software. The
following formula was used to calculate the rate of wound
closure (Walker, 1969):
Walker’s formula:
		
Wound area on day ×			
Wound area % = 				
× 100
		
Wound area measured on day 1
Wound healing percentage = 100 – percentage of the
wound area
2.10. Determination of wound healing
The bandages were changed daily throughout the 21 days
and medication was applied each time this occurred.
Each wound was evaluated for the presence of exudate or
other abnormalities and for wound appearance when the
bandages were changed. The macroscopic reepithelization
criteria of Geronemus et al. (1979) were used for
determining the day of full healing of the wound (pink
appearance on the wound without scab and complete
closure of the wound). Macroscopic reepithelization was
evaluated as “present” or “absent” on days 7, 14, and 21.
2.11. Histological examination
Following the evaluation of the wounds on day 21,
the rats received high-dose anesthesia and were then
exterminated. Excisional biopsy was performed on the
tissue samples including the edges and the surface of each
wound for histological examination. The tissues were
fixed in 10% neutral formalin for 2 days. They were then
washed and dehydrated by incubating them in increasing
concentrations of alcohol.
They were rendered transparent in xylol and embedded
in paraffin. Sections of 5 µm were obtained using a Leica RM
2125 RT. The sections were then stained using Crossman’s
modified triple staining method. The slides were examined
under an Olympus BX50 microscope with regard to
epithelialization, collagen, fibroblasts, inflammatory cells,
and new vessel formation. No finding (-) was scored as 0,
partial/poor (+) was scored as 1, completed but immature
or mild (++) was scored as 2, completed and mature/
moderate (+++) was scored as 3, and significant (++++)
was scored as 4. Images were recorded using an Olympus
DP 25 camera.
2.12. Statistical analysis
Analysis of the study data was carried out using SPSS 20.0
(IBM Corp., Armonk, NY, USA). The descriptive statistics
of continuous variables were expressed as mean, standard

deviation (SD), median, and minimum and maximum
values, and the descriptive statistics of the categorical
variables were expressed as frequency and percentages.
The suitability of the continuous variables to normal
distribution was investigated with the Shapiro–Wilk test.
The Kruskal–Wallis test was used for the comparison of
the four independent groups including nonnormally
distributed variables, and the Bonferroni corrected Mann–
Whitney U test was used for the subgroup comparisons.
The differences between the dependent groups (differences
between measurements at different times) were compared
using Wilcoxon’s test. Pearson’s chi-square test was used
for the intergroup comparison of the categorical variables.
P < 0.05 was accepted as statistically significant.
3. Results
The mean weights of the rats were 245 ± 9 g at the beginning
of the study, 238 ± 21 g on day 7, 251 ± 23 g on day 14, and
264 ± 25 g on day 21.
3.1. Wound healing percentages
Table 1 shows the healing percentages of all groups on days
7, 14, and 21. The group with the highest percentage of
healing was bitter melon and the lowest was nitrofurazone.
A significant difference was observed between the groups
with regard to the healing percentages on days 7 and
14 (respectively P = 0.022 and P = 0.003). Although the
wound healing percentage on day 7 and 14 in the bitter
melon group was higher than that of the nitrofurazone
and saline (control) groups (P = 0.004), no significant
difference was observed compared to the olive oil group (P
> 0.05). However, the difference between the groups was
not significant on day 21 (P = 0.052) (Table 1; Figures 2
and 3).
3.2. Macroscopic reepithelialization
No macroscopic reepithelialization (complete healing
and closure of the wound) was observed in the wounds
of the treatment and saline (control) groups on days 7
and 14, whereas it was observed in 9 wounds (75%) in
the bitter melon group, in 6 wounds (50%) in the olive oil
group, and in 3 wounds (25%) in the nitrofurazone and
saline (control) groups on day 21, which was statistically
significant (χ2 = 3.641, P = 0.046).
3.3. Histological examination
When the wounds were evaluated according to
the histological examination criteria, the highest
epithelialization rate was observed in the bitter melon
extract group (2.29 ± 1.64), which was followed by the
olive oil group (1.83 ± 1.57), on day 21. Histological
examinations revealed the highest collagen formation rate
in the olive oil group (3.08 ± 0.60), which was followed
by the bitter melon group (2.92 ± 0.67). The collagen
formation rate was lowest in the nitrofurazone group (2.29
± 0.50). Fibroblast formation was significantly higher in the
bitter melon (3.38 ± 0.59) and olive oil (2.75 ± 0.50) groups,
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Day 0

Day 7

χ2 = 9.936, P = 0.022*

Total wound healing
(%)
Mean ± SD (%)
Median (min-max)
39.9 ± 15.6a
41.62 (16.37–60.00)
33.5 ± 15.8a
37.44 (3.37–54.62)
21.4 ± 7.7b
20.87 (9.62–35.0)
28.0 ± 14.1b
30.88 (3.75–50.5)

Total wound
healing (%)
Mean ± SD (%)
Median (min-max)
78.4 ± 11.4a
83.12 (64.0–91.62)
77.5 ± 13.2a
78.94 (52.5–95.5)
62.0 ± 9.5b
64.19 (45.5–78.62)
77.2 ± 7.6b
75.75 (62.75–89.25)

χ2 = 14.084, P = 0.003*

Unhealed wound
area (cm2)
Mean ± SD (cm2)
Median (min-max)
0.86 ± 0.46a
0.67 (0.33–1.84)
0.88 ± 0.53a
0.67 (0.33–1.84)
1.52 ± 0.38b
1.43 (0.85–2.18)
0.91 ± 0.30b
0.97 (0.43–1.49)

Day 14

*Kruskal–Wallis test, P < 0.05.
a,b
Different superscripts within the same column indicate significant difference among groups.

χ2*, P-value

Wound area Unhealed wound
(cm2)
area (cm2)
Mean ± SD (cm2)
Median (min-max)
2.40 ± 0.63a
Bitter Melon 4.00 ± 0
2.33 (1.60–3.34)
2.67 ± 0.63a
Olive Oil
4.00 ± 0
2.52 (1.81–3.86)
3.14 ± 0.31b
Nitrofurazone 4.00 ±0
3.16 (2.60–3.61)
Saline
2.68 ± 0.40b
4.00 ± 0
(control)
2.68 (1.98–3.34)

Group

χ2 = 7.731, P = 0.052

Unhealed wound
area (cm2)
Mean ± SD (cm2)
Median (min-max)
0.22 ± 0.23
0.14 (0–0.64)
0.25 ± 0.24
0.21 (0–0.68)
0.54 ± 0.36
0.62 (0.04–1.06)
0.31 ± 0.17
0.31 (0–0.65)

Day 21

Table 1. Comparison of the mean unhealed wound areas and healing percentages of the wounds in the treatment and control groups.

Total wound healing
(%)
Mean ± SD (%)
Median (min-max)
94.7 ± 5.8
96.56 (84.0–100.0)
93.7 ± 6.0
94.81 (82.87–100.0)
86.3 ± 8.9
84.44 (73.37–99.0)
92.3 ± 4.4
92.25 (83.75–100.0)
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Bitter Melon Group
Day 0

Olive Oil
Day 0

Nitrofurazone Group
Day 0

Saline Group
Day 0

Day 7

Day 7

Day 7

Day 7

Day 14

Day 14

Day 14

Day 14

Day 21

Day 21

Day 21

Day 21

Figure 2. Progression of wound healing in the bitter melon, olive oil, nitrofurazone, and control groups from day 0 to day 21.

Wound Area (% of day 0)

100
80
60
40
20
0

0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
bitter meton

olive oil

nitrofurazone

saline

Figure 3. Quantitative analysis of wound areas per group, expressed as
percentage of the initial wound size at day 0.

whereas it was low in the saline (control) and nitrofurazone
groups, and this was found to be a statistically significant
difference (P < 0.001). Inflammatory cell formation was
highest in the saline (control) group (2.75 ± 0.84) and
lowest in the bitter melon group (2.25 ± 0.97); however, no
difference was observed between the groups with regard
to mean inflammatory cell scores (P = 0.354). New vessel
formation was highest in the bitter melon group (3.54 ±

0.62); however, the difference between the groups was not
statistically significant (P = 0.124) (Table 2; Figures 4–7).
4. Discussion
Wound healing is a complex process that comprises three
phases of inflammation, proliferation, and maturation,
and it involves the well-organized and highly complex
interaction of different tissues and cells (Agyare et al., 2016;
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Table 2. Comparison of the mean histological scores of the wounds in the treatment and control groups.

Histological scores
Epithelialization scores
Collagen scores
Fibroblast scores
Inflammatory cell scores
New vessel scores

Bitter melon

Olive oil

Nitrofurazone

Saline (control)

Mean ± SD
Median (min–max)
2.29 ± 1.64
2.00 (0–4.0)
2.92 ± 0.67
2.75 (2.0–4.0)
3.38 ± 0.59
3.50 (2.5–4.0)
2.25 ± 0.97
2.00 (1.0–4.0)
3.54 ± 0.62
3.75 (2.0–4.0)

Mean ± SD
Median (min–max)
1.83 ± 1.57
2.00 (0–4.0)
3.08 ± 0.60
3.00 (2.0–4.0)
2.75 ± 0.50
2.75 (2.0–3.5)
2.33 ± 0.81
2,50 (1,0–4,0)
2.92 ± 1.06
3.25 (1.0–4.0)

Mean ± SD
Median (min–max)
0.83 ± 1.03
0 (0–2.0)
2.29 ± 0.50
2.0 (1.5–3.0)
2.08 ± 0.42
2.0 (1.5–3.0)
2.58 ± 0.56
2.5 (1.5–3.5)
3.29 ± 0.69
3.5 (2.0–4.0)

Mean ± SD
Median (min–max)
0.21 ± 0.58
0 (0–2.0)
2.67 ± 0.44
3.0 (2.0–3.0)
2,25 ± 0,45
2.0 (1.5–3.0)
2.75 ± 0.84
2.5 (1.5–4.0)
2.75 ± 0.94
2.75 (1.0–4.0)

χ2* value P-value
17.082

0.001*

10.546

0.014*

24.742

0.000**

3.253

0.354

5.754

0.124

*Kruskal–Wallis test, P < 0.05, **P < 0.001.

Figure 4. It was observed that fibrosis occurred by completing the epithelialization, new vessel formation was significant, and leukocyte
infiltration was low in the section taken on day 21 in the bitter melon group. Epidermis layer (E), keratin layer (large arrow), blood
vessel wall (small arrow), leukocyte infiltration (L); Crossman’s modified triple staining, 1 bar = 200 µm.

Figure 5. It was observed that epithelialization was completed, collagen formation was significant, new vessel formation was moderate,
and leukocyte infiltration was low in the section taken on day 21 in the olive oil group. Epidermis layer (E), keratin layer (large arrow),
blood vessel wall (small arrow), collagen formation (K), leukocyte infiltration (L); Crossman’s modified triple staining, 1 bar = 200 µm.

Jarić et al., 2018). Preliminary phytochemical screening
of the extracts of bitter melon showed that there were
tannins, alkaloids, flavonoids, glycosides, and saponins
in the extract. Tannins are known to have antimicrobial,
astringent, and protein coagulatory properties that aid
in wound healing (Agyare et al., 2014; Nagarani et al.,
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2014; İlhan et al., 2015; Zhang et al., 2016; Jia et al. 2017).
Previous studies revealed the wound healing activity
of bitter melon, and the promotion of wound healing
through antiinflammatory and antibacterial effects and
the stimulation of angiogenesis and fibroblast activity
has been demonstrated in animal studies (Ilango et al.,
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Figure 6. It was observed that epithelialization was incomplete, collagen formation was mild, and leukocyte infiltration was moderate
in the section taken on day 21 in the nitrofurazone group. Incomplete epithelialization (thick arrow), mild degree of collagen formation
(K), leukocyte infiltration (L); Crossman’s modified triple staining, 1 bar = 200 µm.

Figure 7. It was observed that epithelialization had not occurred and leukocyte
infiltration was significant in the section taken on day 21 in the control group. Incomplete
epithelialization (thick arrow), significant level of leukocyte infiltration (L); Crossman’s
modified triple staining, 1 bar = 200 µm.

2010; Prashanthi et al., 2012; Satar et al., 2013; Hussan et
al., 2014; Pişkin et al., 2014; İlhan et al. 2015; Singh et al.
2017). Furthermore, in a different study, it was reported
that bitter melon fruit extract-based PLA/Ag nanofibers
used as wound healers can enhance the proliferation and
function of epidermal cells and fibroblasts (Alippilakkotte
et al., 2017).
Measurement of the wound area and change in the
surface area of the wound provides objective evidence
of the wound healing process. In this study, the wound
closure rate in the bitter melon group was 1.5 times greater
than that of the olive oil group and 3 times greater than
that of the nitrofurazone and the saline (control) groups.
The increased epithelialization, fibroblast density, and new
vessel formation in the bitter melon group revealed in
histological examinations also confirmed this difference.
The literature on the positive efficacy of bitter melon on
wound healing is promising. In a study on rats, the wound
closure rates in the group treated with bitter melon were
twice as fast as those of the control group. Additionally,
the hydroxyproline level in granulation tissue, which is
an important indicator of the wound healing process and

is used as a marker of the amount of collagen in tissue,
was reported to be higher in the bitter melon group
(Prashanthi et al., 2012). Likewise, in another study, the
olive oil macerate of bitter melon showed significant wound
healing activity both in incision and excision wounds and
significant enhancement in hydroxyproline content in
buccal mucosa wounds in rats (İlhan et al., 2015).
Wound closure is influenced by the formation
and maturation of collagen. In our study, the highest
epithelialization was observed in the bitter melon group,
and collagen formation was higher in the olive oil group.
In a similar study conducted on rabbits, the wounds
were treated with bitter melon extract, olive oil, and a
no-treatment protocol. The wounds were observed to be
completely closed in the bitter melon group on day 28,
and the time for complete closure was significantly shorter
compared to the pure olive oil group (Satar et al., 2013).
In another study, wounds formed in rabbits were treated
with dexpanthenol, bitter melon, and nitrofurazone.
Mild collagen fiber formation and a high rate of vessel
formation were observed in the group treated with bitter
melon (Pişkin et al., 2014). Singh et al. (2017) reported that
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topical extracts of bitter melon can increase the formation
of granulation tissue. Hussan et al. (2014) reported that
bitter melon ointment can accelerate ulcer healing and
increase TGF-β 52 expression. In another study conducted
by Agyare et al. (2014) it was found that bitter melon
extract increased collagenation in the wound tissue and
the rate of wound closure. Our results also support the
literature.
Antiinflammatory activity is essential for the wound
healing process, since long periods in the inflammatory
phase results in retardation of healing. Administration
of antiinflammatory and antioxidant agents may be
beneficial in healing skin wounds (İlhan et al., 2015). It
has been reported that bitter melon has higher potential
antioxidant and antiinflammatory activities (Nagarani et
al., 2014; Aljohi et al., 2016; Wang et al., 2017). Likewise,
in the study conducted by İlhan et al. (2015), bitter
melon extract showed significant wound healing and
antiinflammatory effects. In our study, inflammatory
cell formation was lowest in the bitter melon group. The
efficacy of bitter melon on wound healing may be related
to its antiinflammatory effects, which reduce the bacterial
load of the wound and increase epithelial proliferation.
Furthermore, bitter melon contains high amounts of
vitamin A, which is necessary for epithelial keratinization
and formation of collagen cross-fibers; vitamin C, which
is a strong antioxidant; and zinc, which is known to play
a key role in wound healing. The high collagen formation
scores observed in the wounds in the bitter melon group
in this study are consistent with findings in the literature
(Prashanthi et al., 2012; Agyare et al., 2014).
Oxidative stress, known to be caused by excessive
oxidants, is very important in wound healing because it
causes further damage to tissues and therefore reduces
or delays the healing process. It has been reported in
the literature that the analgesic and antiinflammatory
activities of bitter melon accelerate capillary circulation,
thereby increasing oxygenation, which is an important
factor in wound healing, and that the antiinflammatory
and antioxidant activities reduce the harm caused by free
radicals formed as a result of the inflammation and prevent
the progression of necrosis (Kumar and Bhowmik, 2010;
Agyare et al., 2014; Aljohi et al., 2016; Rosyid et al., 2018).
The optimum environment for epithelialization is a
moist environment. Moreover, it has been reported that
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the hypoxic environment under moist wound dressings
increased capillary proliferation; angiogenesis is faster
in moist conditions (Boateng and Catanzano, 2015). In
an in vitro study conducted by Aljohi et al. (2018), it was
reported that the methanolic extract of bitter melon had
angiogenic effects. Singh et al. (2017) reported that extracts
of bitter melon topically can increase angiogenesis. Similar
to the literature, in our study it was found that new vessel
formation was highest in the bitter melon group. These
observations support the beneficial effects of topical bitter
melon extracts on wound healing.
The most obvious finding to emerge from this study is
that the healing rate observed in the bitter melon group
was significantly faster than that seen in the nitrofurazone
and the saline (control) groups, and that the healing rate
in the olive oil group was close to the one observed in the
bitter melon group. The promising outcomes observed in
wound healing using bitter melon extract could form a
basis for controlled clinical studies. In this respect, since
preparation of the bitter melon and pure olive oil is easy
and the economic aspects are favorable, it could be used
as an alternative treatment option in the treatment of
wounds. Controlled clinical studies should be conducted
on individuals with chronic wounds that are difficult and
time-consuming to treat.
However, this study has some limitations. This was an
in vitro study. One limitation of this study was that it was
not a clinical study performed on humans due to time,
ethical concerns, and budget. Another limitation was that
it was not a blinded study due to its design. In addition,
we know that there are many factors that can affect wound
healing and that may interfere with one or more phases
in this process. In this study, we were not able to examine
and control all these factors, and they may have affected
our results. Furthermore, the 21-day follow-up was also
a limitation. We could not investigate the biochemical
pathways through which the bitter melon has its healing
effect nor analyze the active substances in the plant extract
due to our limited budget.
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